Journal Article Summary
The article explores the development of dissolvable microarray patches (MAP) as a novel drug delivery system, emphasizing the challenges in their preclinical evaluation. These patches can effectively deliver medications through the skin, but the lack of standardized testing protocols has hindered their regulatory approval and clinical use. By utilizing Physiologically Based Pharmacokinetic (PBPK) modeling, the study aims to improve the understanding of how drugs behave in the body after being delivered via MAP, addressing issues related to variability in experimental conditions and the complexity of skin physiology.
The researchers optimized an existing PBPK model to better predict drug distribution and absorption from dissolvable MAP. They incorporated specific parameters related to the geometry of the microneedles and the release profiles of three different drugs: chlorpheniramine maleate, loratadine, and itraconazole. The model was validated through both in vitro tests using porcine skin and in vivo studies in pigs, demonstrating strong predictive performance across various conditions and drug types, which could accelerate the development of MAP for clinical use.
However, the study acknowledges several limitations, including the complexity of accurately modeling the interactions between MAP design and skin characteristics. The model assumes uniform microneedle insertion and does not account for variations in drug release due to different formulations. Patients and caregivers should discuss these findings with healthcare professionals, especially regarding the potential benefits and risks of using MAP for drug delivery, as well as the importance of ongoing research to refine these models for better accuracy in predicting drug behavior in humans.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Railic Maja, de Witte Wilhelmus E. A., Schaller Stephan, Agboola Sarah Toluwanimi, Sartawi Ziad, Faisal Waleed, Elkhashab Mohamed, Crean Abina, et al.. From simulation to application: enhancing preclinical evaluation of dissolvable microarray patches through PBPK modelling. Drug Delivery and Translational Research 2025. DOI: 10.1007/s13346-025-01974-x. PMID: 41073847. PMCID: PMC13038671.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
